CRISPR Therapeutics AG - Common Shares (NQ:CRSP)
Price and Volume
Detailed Quote| Volume | 567,730 |
| Open | 51.48 |
| Bid (Size) | 51.54 (100) |
| Ask (Size) | 51.82 (100) |
| Prev. Close | 49.99 |
| Today's Range | 50.19 - 52.46 |
| 52wk Range | 44.12 - 64.74 |
| Shares Outstanding | 78,935,098 |
| Dividend Yield | N/A |
Top News
More News
Performance
52-Week Range
20.4% below 52-week high
51.54
44.1252W Low
64.7452W High
1 Week
7.7% below 1-week high
49.621W Low
55.821W High
CRISPR Therapeutics AG - Common Shares (CRSP) traded between $44.12 and $64.74 over the past 52 weeks and last traded at $51.54, 20.4% below its 52-week high. Over the past week it ranged between $49.62 and $55.82.
Past 12 Months
-4.7%
-10.1%
-2.9%
-1.6%
-4.1%
-16.8%
1W
-$2.57
1M
-$5.80
3M
-$1.53
6M
-$0.84
YTD
-$2.23
1Y
-$10.43
CRSP was -16.8% over the past year, -1.6% over six months, -4.1% year to date, -4.7% in the last week.
12 Months vs Market
CRSP
-16.8%
DIA
+12.5%
SPY
+12.4%
QQQ
+9.7%
IWM
+15.7%
Over the past 12 months CRSP returned -16.8% versus DIA (Dow) +12.5%, SPY (S&P 500) +12.4%, QQQ (Nasdaq 100) +9.7% and IWM (Russell 2000) +15.7%.
Volume & Liquidity
0.37× 3-mo avg
Today 567,730
3-mo avg 1.5M
1W
1.2M
1M
1.5M
3M
1.5M
6M
1.6M
YTD
1.7M
1Y
1.8M
CRSP most recently traded 567,730 shares against a 3-month average daily volume of 1.5M.
More News
Read More
Where Will CRISPR Therapeutics Stock Be in 2030? ↗
October 18, 2026
Via The Motley Fool
3 Reasons CRISPR Therapeutics Stock Is Still a Buy After a Rocky 2026 ↗
September 20, 2026
Via The Motley Fool
CRISPR Therapeutics Eyes CASGEVY Growth, Year-End Pipeline Catalysts ↗
September 14, 2026
Via MarketBeat
Topics
Intellectual Property
AbbVie vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026? ↗
September 14, 2026
Via The Motley Fool
Via The Motley Fool
Via The Motley Fool
Why CRISPR Therapeutics Stock Rocked the Market Last Month ↗
September 08, 2026
Via The Motley Fool
Where Will CRISPR Therapeutics Stock Be in 5 Years? ↗
September 08, 2026
Via The Motley Fool
Via The Motley Fool
3 Stocks With the Most Upside by the End of 2026 ↗
July 30, 2026
Via The Motley Fool
Topics
Workforce
Via The Motley Fool
Frequently Asked Questions
Is CRISPR Therapeutics AG - Common Shares publicly traded?
Yes, CRISPR Therapeutics AG - Common Shares is publicly traded.
What exchange does CRISPR Therapeutics AG - Common Shares trade on?
CRISPR Therapeutics AG - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for CRISPR Therapeutics AG - Common Shares?
The ticker symbol for CRISPR Therapeutics AG - Common Shares is CRSP on the Nasdaq Stock Market
What is the current price of CRISPR Therapeutics AG - Common Shares?
The current price of CRISPR Therapeutics AG - Common Shares is 51.54
When was CRISPR Therapeutics AG - Common Shares last traded?
The last trade of CRISPR Therapeutics AG - Common Shares was at 11/04/26 11:56 AM ET
What is the market capitalization of CRISPR Therapeutics AG - Common Shares?
The market capitalization of CRISPR Therapeutics AG - Common Shares is 4.07B
How many shares of CRISPR Therapeutics AG - Common Shares are outstanding?
CRISPR Therapeutics AG - Common Shares has 4B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>